PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
NCT ID: NCT05620186
Last Updated: 2024-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2017-10-17
2027-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Results from a previous randomised controlled trail can be reproduced in real life.
* Evaluate skills retention after program completion.
* Assess real life implementation of the training program.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Surgical trainees completing PROSPECT showed superior real live endovascular performance compared to the traditionally trained in a single centre randomised controlled trial (RCT). The curriculum was integrated locally, but also introduced in other centers: national and international. Local tutors teach the curriculum to trainees after standardized training on the modalities of PROSPECT by the researchers of the Ghent.
A registry is maintained and coordinated by the Ghent research group in which all educational data regarding this training is collected and processed anonymously.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Original PROSPECT
Original, distributed PROSPECT where trainees learn at their own pace in between, before/after clinical activities
PROSPECT
PROficiency Based StePwise Endovascular Curricular Training
Massed PROSPECT
Massed, bootcamp-style training form of PROSPECT where trainees are exempt from clinical duties
PROSPECT
PROficiency Based StePwise Endovascular Curricular Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PROSPECT
PROficiency Based StePwise Endovascular Curricular Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Knowledge and technical skill level evaluated
* Demographics questionnaire and general MCQ test completed
* Endovascular simulated exercise completed after familiarization with the simulator
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle Van Herzeele, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ghent
Ghent, , Belgium
KU Leuven
Leuven, , Belgium
CAMES
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Isabelle Van Herzeele, MD, PhD
Role: primary
Inge Fourneau, MD, PhD
Role: primary
Jonas Eiberg, MD, Phd
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BC-877
Identifier Type: -
Identifier Source: org_study_id